Charles River Laboratories International, Inc.
A maker of research animals and drug-development services, Charles River Laboratories supplies the lab rats, mice, and testing that pharmaceutical and biotech companies rely on to bring new medicines to market. It began in 1947 when a young veterinarian, Dr. Henry Foster, started a one-man operation in a Boston loft overlooking the Charles River—the source of its name—personally breeding and hand-delivering the animals to local scientists. Foster paid for his first thousand rat cages with savings from a job as a vet on ships hauling horses to Poland.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Invesco Ltd. | 13GPassive | 6.2% | 2.98M | Aug 13, 2026 |
| FMR LLC | 13G/APassive | 8.8% | 4.24M | Aug 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 8.8% | 4.24M | Aug 6, 2026 |
| Vanguard Capital Management | 13GPassive | 7.38% | 3.63M | Apr 29, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| Wellington Management Group LLP | 13G/APassive | 3.6% | 1.75M | Feb 10, 2026 |
| Wellington Group Holdings LLP | 13G/APassive | 3.6% | 1.75M | Feb 10, 2026 |
| Wellington Investment Advisors Holdings LLP | 13G/APassive | 3.6% | 1.75M | Feb 10, 2026 |
| NOMURA HOLDINGS INC | 13G/APassive | 1.6% | 807.9K | Nov 14, 2025 |
| BlackRock, Inc. | 13G/APassive | 6.9% | 3.52M | Apr 17, 2025 |